Pan drug-resistant Acinetobacter baumannii causing nosocomial infections among burnt children

Behnam Sobouti1, Maryam Mirshekar2,3, Shahrzad Fallah4

  • 1Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.

Insights

Multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan drug-resistant (PDR) Acinetobacter baumannii strains are a significant threat in burnt children. Clinical microbiology labs must evaluate these resistant strains to combat antimicrobial resistance.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Nosocomial infections caused by Acinetobacter baumannii are a growing global concern due to increasing multidrug resistance (MDR).
  • Antibiotic-resistant A. baumannii strains pose a persistent challenge in treating infected patients, necessitating ongoing surveillance.

Purpose of the Study:

  • To monitor and characterize antibiotic resistance patterns among Acinetobacter baumannii strains isolated from pediatric burn patients.
  • To identify the prevalence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan drug-resistant (PDR) A. baumannii in this vulnerable population.

Main Methods:

  • Biochemical identification confirmed 62 Acinetobacter baumannii isolates from 115 initial samples.
  • Minimum Inhibitory Concentration (MIC) tested colistin susceptibility; disk agar diffusion assessed resistance to Ciprofloxacin, Amikacin, Gentamicin, Cefepime, Meropenem, Imipenem, Ceftazidime, Levofloxacin, and Piperacillin/Tazobactam.
  • Isolates were classified as MDR, XDR, or PDR based on established antimicrobial susceptibility criteria.

Main Results:

  • Out of 62 A. baumannii strains, 58% (36/62) were classified as multidrug-resistant (MDR).
  • A significant proportion were extensively drug-resistant (XDR) at 27.5% (17/62), and 14.5% (9/62) exhibited pan drug resistance (PDR).
  • These findings highlight a high prevalence of severe antibiotic resistance in pediatric burn infections.

Conclusions:

  • The study underscores the critical need for clinical microbiology laboratories to actively evaluate MDR, XDR, and PDR Acinetobacter baumannii strains.
  • Effective monitoring and reporting of these resistant strains are essential steps in mitigating the global threat of antimicrobial resistance, particularly in immunocompromised patient populations like burnt children.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
161
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
620
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
3.8K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
340